Impact of Achieving Minimal Disease Activity on Patient-Reported Outcome Measures and Disease Activity Among Patients with Psoriatic Arthritis Treated with Biologic and Targeted Synthetic DMARDs

被引：0

作者：

Ogdie, Alexis ^{[1
]}

McLean, Robert ^{[2
]}

Marchese, Maya ^{[2
]}

Blachley, Taylor ^{[2
]}

Anatale-Tardiff, Laura ^{[3
]}

Saffore, Christopher ^{[4
]}

Douglas, Kevin ^{[5
]}

Quach, Danny ^{[5
]}

Mease, Philip ^{[6
,7
]}

机构：

[1] Univ Penn, Philadelphia, PA 19104 USA

[2] CorEvitas LLC, Waltham, MA USA

[3] CorEvitas, Waltham, MA USA

[4] AbbVie, N Chicago, IL 60064 USA

[5] AbbVie Inc, N Chicago, IL USA

[6] Swedish Med Ctr Providence St Joseph Hlth, Seattle, WA USA

[7] Univ Washington, Seattle, WA 98195 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1344

引用

页码：2798 / 2801

页数：4